Alteration of drug biotransformation and elimination during infection and inflammation
- 26 November 2001
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 92 (2-3) , 147-163
- https://doi.org/10.1016/s0163-7258(01)00165-6
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Differential Effects of Interleukin-1β, Interleukin-2, and Interferon-γ on the Inducible Expression of CYP 1A1 and CYP 1A2 in Cultured Rabbit HepatocytesBiochemical and Biophysical Research Communications, 1997
- Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-α/β inductionLife Sciences, 1997
- Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor αGastroenterology, 1995
- Interferon suppresses erythromycin metabolism in rats and human subjectsHepatology, 1993
- Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 IA1, IA2 and IIIA3 in human hepatoma cellsBiochemical and Biophysical Research Communications, 1992
- Effects of Subchronic Treatment with Natural Human Interferons on Antipyrine Clearance and Liver Function in Patients with Chronic HepatitisThe Journal of Clinical Pharmacology, 1990
- Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in miceLife Sciences, 1987
- Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducersBiochemical and Biophysical Research Communications, 1984
- Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformationBiochemical and Biophysical Research Communications, 1982
- Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agentsBiochemical and Biophysical Research Communications, 1976